Open access
84
Views
0
CrossRef citations to date
0
Altmetric
Post Hoc Analysis
Identifying factors associated with clinical success in patients treated with NASHA®/Dx injection for fecal incontinence
Howard Franklin1 Department of Medical Affairs, Salix, a Division of Valeant Pharmaceuticals North America LLC, Bridgewater, NJ, USA
, Andrew C Barrett1 Department of Medical Affairs, Salix, a Division of Valeant Pharmaceuticals North America LLC, Bridgewater, NJ, USA
& Ray Wolf2 Department of Medical Affairs, Valeant Pharmaceuticals North America LLC, Wilton Manors, FL, USACorrespondence[email protected]
Pages 41-47
|
Published online: 02 Mar 2016
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.